pharmasnewcommercialreality.blogspot.com

previouslyimpossible.wordpress.com

New Drugs: The Future of Approval & Safety | Life Science Computing

https://previouslyimpossible.wordpress.com/2011/01/11/new-drugs-the-future-of-approval-safety

Advances in health with faster, smarter uses of more data. New Drugs: The Future of Approval & Safety. January 11, 2011 in BI. Pharma Sales and Marketing. 2010 was a lean year for new drug approvals. The FDA granted permission for only 21 new medicationsbelow both the 2009 and 2008 levels. Some of the most eagerly awaited approvals have been delayed. Many see the low numbers as a trend. Courtesy of the WSJ. Armed with more legal power through the passage of the FDA Amendments Act. Lofty but achievable go...

digitalpharm.blogspot.com

Digital Pharma: Managing Diabetes on an iPhone

http://digitalpharm.blogspot.com/2010/11/managing-diabetes-on-iphone.html

Sunday, November 28, 2010. Managing Diabetes on an iPhone. Merck's introduction of a mobile app for patients with Type 2 diabetes (Vree) is an innovative way to manage the disease. A more recent announcement last week reminded me of Merck's introduction of the mobile app - a report that half the country could have diabetes by 2020, with costs totaling $3.35 trillion over the next decade if trends continue. Subscribe to: Post Comments (Atom). Pharmaceutical R&D Blog, Stuart Henderson.

digitalpharm.blogspot.com

Digital Pharma: Social Media Guidance and the Art of Patience

http://digitalpharm.blogspot.com/2010/11/social-media-guidance-and-art-of.html

Monday, November 1, 2010. Social Media Guidance and the Art of Patience. The FDA recently gave Novartis a slap on the hand for "misusing" the Facebook Share widget on its website for the drug Tasigna. The violation? Failing to communicate risks associated with the drug. Should Novartis be blamed for this oversight? Others, however, are proposing a different tactic: First Amendment rights. Pfizer and the Washington Legal Foundation filed a brief with a U.S. District Court in March to uphold Fi...Pharma Ad...

digitalpharm.blogspot.com

Digital Pharma: Grading Pharma's Use of YouTube (A First Look)

http://digitalpharm.blogspot.com/2011/01/grading-pharmas-use-of-youtube-first.html

Friday, January 28, 2011. Grading Pharma's Use of YouTube (A First Look). While the pharma industry experiments with social media, several pharma companies are maintaining dedicated YouTube channels, among them Pfizer (PfizerNews, PfizerEurope), Johnson and Johnson (JNJHealth), GlaxoSmithKline (GSKVision), and Boehringer (BoehringerIngelheim). Better yet, what value are its patients getting out of it? If I were to compare both companies' channels, Pfizer would receive a grade of D while J&J would be awar...

digitalpharm.blogspot.com

Digital Pharma: Perspective on Social Media in Pharma

http://digitalpharm.blogspot.com/2010/10/perspective-on-social-media-in-pharma.html

Thursday, October 21, 2010. Perspective on Social Media in Pharma. There are two compelling reasons that stick out in my mind for pharma companies to embrace social media as an enduring strategy:. 1) To Build the Brand. 2) To Improve Patient Safety. The amount of information on the web about this opportunity is tremendous - here I will mention a couple of broad opportunities that I find most interesting. Subscribe to: Post Comments (Atom). Pharmaceutical R&D Blog, Stuart Henderson.

previouslyimpossible.wordpress.com

July | 2011 | Life Science Computing

https://previouslyimpossible.wordpress.com/2011/07

Advances in health with faster, smarter uses of more data. Archive for July, 2011. Tight Budgets: An Unexpected Force Driving the Adoption of Health IT. July 29, 2011 in BI. Electronic Health Record Analytics. The Healthcare IT market. Is expected to grow at a CAGR of about 24% during 2012 to 2014. What other sectors can boast such a rate in this economy? It is anticipated to be a $40 billion industry by the end of 2011. Why? The urgency for significant HIT adoption is unavoidably clear:. Can reduced the...

previouslyimpossible.wordpress.com

China’s Healthcare Reform: Fastest Growing Sector in the World | Life Science Computing

https://previouslyimpossible.wordpress.com/2010/11/09/china’s-healthcare-reform-fastest-growing-sector-in-the-world

Advances in health with faster, smarter uses of more data. China’s Healthcare Reform: Fastest Growing Sector in the World. November 9, 2010 in BioInformatics. Electronic Health Record Analytics. The most populated country in the world is fully engaging the issues of healthcare reform. The cornerstone of the newly emerging system is patient data. The organization, storage and management of health records will ultimately maximize the benefits of patient care and cost efficiency. Before the information from...

previouslyimpossible.wordpress.com

Merging Nanopores, DNA Sequencing and Cost | Life Science Computing

https://previouslyimpossible.wordpress.com/2010/10/22/merging-nanopores-dna-sequencing-and-cost

Advances in health with faster, smarter uses of more data. Merging Nanopores, DNA Sequencing and Cost. October 22, 2010 in Data Mining. The day when a cost efficient technology. For reading and sequencing DNA is available may be closer at hand. Intense research is focused on refining the most promising techniques. While IBM’s DNA Transistor Technology is in the forefront, efforts at Oxford Nanopore, Sandia National Labs and elsewhere are validating the trend. No matter how long it takes for the technolog...